OmniaManufacturing Services for Novel Biologics

Cells
About the images

Company Profile

Omnia offers an array of manufacturing and process development services for companies engaged in the development of novel biologics. Our experience in many of these areas – from preclinical gene therapeutics through commercial recombinant proteins – gives Omnia a unique and specialized approach for developing manufacturing processes.

The company has both non-GMP and GMP facilities for process development through Phase I/II manufacture.


Technical Focus: 
- Adenovirus
- Lentivirus
- Retrovirus
- AAV
- VLP
- Other viral platforms 

Contact us to meet at our scheduled
Conferences and Tradeshows:

  • AACR annual meeting (New Orleans, Louisiana, April 16-20, 2016)
  • ASGCT annual meeting (Washington D.C., May 4-7, 2016
  • 14th Annual Vaccines and Therapeutics(Washington D.C., May 17-19, 2016)
  • ESGCT Congress (Florence, Italy, October 18-21, 2016) 
  • SITC annual meeting (National Harbor, Maryland, November 9-13, 2016)